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Abstract
Background: Persistent arterial dysfunction in patients with a history of Kawasaki disease (KD)
and an integral role of oxidative stress in the development of cardiovascular disease are increasingly
recognized. We sought to test the hypothesis that oxidative stress is increased in KD patients and
related to carotid atherosclerotic changes and stiffness.
Methods: We compared the serum levels of oxidative stress biomarkers, carotid intima-media
thickness (IMT), and carotid stiffness index among KD patients with coronary aneurysms (n = 32),
those without coronary complications (n = 19), and controls (n = 32).
Results:  Compared with controls, patients with coronary aneurysms had significantly higher
serum levels of malonaldehyde (2.62 ± 0.12 μM vs 2.22 ± 0.07 μM, p = 0.014) and hydroperoxides
(26.50 ± 1.13 μM vs 22.50 ± 0.62 μM, p = 0.008). A linear trend of the magnitude of oxidative stress
in relation to inflammatory damage was observed for malonaldehyde (p = 0.018) and
hydroperoxides (p = 0.014) levels. Serum malonaldehyde and hydroperoxide levels correlated
positively with carotid IMT (p < 0.001 and p = 0.034, respectively) and stiffness index (p = 0.001
and p = 0.021, respectively). Multiple linear regression analysis identified serum malonaldehyde
level as a significant determinant of carotid IMT (β = 0.31, p = 0.006) and stiffness (β = 0.27, p =
0.008).
Conclusion: Our findings suggest oxidative stress is increased in KD patients with coronary
aneurysms and is associated with carotid intima-media thickening and stiffening.
Background
Since its first description in 1967 [1], Kawasaki disease
(KD) has become the most common acquired heart dis-
ease in children in developed countries [2]. Patients diag-
nosed with KD in the sixties and early seventies have
reached middle age. Previous studies have demonstrated
persistent coronary arterial dysfunction in patients with
persistent and regressed coronary aneurysm [3-5]. Impor-
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tantly, endothelial dysfunction and stiffening of both the
coronary [3-5] and systemic [6-9] arteries that characterize
the arterial dysfunction are themselves risk factors for pre-
mature atherosclerosis and cardiovascular disease.
Indeed, we [10] and others [7] have found a significant
increase in carotid intima-media thickness (IMT), a
marker of atherosclerosis [11], in KD patients with or
without coronary complications late after the acute ill-
ness. While growing data suggest premature atherosclero-
sis in patients with a history of KD, the underlying
mechanisms remain unclear.
Accumulating evidence suggests that oxidative stress plays
an integral role in the development of atherosclerosis and
cardiovascular disease. Reactive oxygen species are
increasingly recognized to play an important role in com-
promising endothelial function, including modulation of
vasomotor tone [12,13]. Oxidized low-density lipopro-
tein is pro-inflammatory [14,15], causes inhibition of
endothelial nitric oxide synthase [16], promotes retention
of macrophages in the arterial wall [17], and stimulates
vascular smooth muscle cells proliferation [15]. Further-
more, F2-isoprostanes, a biomarker marker of lipid perox-
idation [18], have been found to localize in foam cells in
atherosclerotic lesions of humans [19] and a mouse
model of atherosclerosis [20].
Given the persistent arterial dysfunction and risk of pre-
mature atherosclerosis in KD patients as well as the
increasingly recognized integral role of oxidative stress in
the development of cardiovascular disease, we hypothe-
sized that oxidative stress was increased in KD patients
and related to carotid atherosclerotic changes and stiff-
ness. To test the hypothesis, we compared the levels of two
markers of oxidative stress, malonaldehyde and hydroper-
oxides, in patients with a history of KD with those of
healthy controls and determined the correlations between
levels of these oxidative stress markers and carotid IMT
and stiffness index.
Methods
Subjects
Patients with a history of KD were recruited from the pae-
diatric cardiac clinic. Those diagnosed with KD within 12
months of study were excluded to minimize potential
confounding influence relating to subacute inflamma-
tion. From the case records, the age at diagnosis, the inter-
val from disease onset to the time of study, and the
coronary artery status were noted. Coronary aneurysms
were documented by serial two-dimensional echocardiog-
raphy in all of the patients. None of the patients required
cardiac catheterization. Diagnosis of KD was based on the
classic clinical criteria [21], while diagnosis of coronary
aneurysms was based on the Japanese Ministry of Health
criteria [22]. Healthy age-matched subjects were recruited
as controls were recruited as control subjects. These were
healthy children previously discharged from our clinic
with a diagnosis of a functional heart murmur and their
healthy siblings. The body weight and height were meas-
ured, and body mass index was calculated accordingly.
The blood pressure in the right arm was measured twice
using an automated oscillometric device (Dinamap, Cri-
tikon, Inc), and the average of the 2 readings was taken.
The institutional Ethics Committee approved the study
and parents of all subjects gave written, informed consent.
Measurement of carotid IMT and stiffness
A 7–15 MHz linear-array transducer, interfaced to a
Hewlett-Packard Sonos 5500 ultrasound machine, was
used to image the right carotid artery at about 1 cm prox-
imal to the carotid bifurcation. The IMT of the right com-
mon carotid artery far wall was measured offline using the
QLAB analysis software (Philips, Bothell, USA). The QLAB
IMT plug-in detects automatically the intima-media pixel
pairs along the far wall of the carotid artery and provides
a spatially averaged measurement of IMT over a preset of
10 mm region of interest. The average of three measure-
ments was used for subsequent analysis.
The carotid artery stiffness was assessed by calculating the
stiffness index as reported previously [23]. The end-
diastolic (Dd) and systolic (Ds) diameters were measured.
The carotid arterial stiffness index was then calculated as:
ln (SBP/DBP)/[(Ds-Dd)/Dd], where SBP and DBP are
systolic and diastolic blood pressure, respectively. The
average of the right carotid arterial stiffness index derived
from the values of three consecutive cardiac cycles was
used for subsequent analyses.
Blood investigations
Venous blood was withdrawn for measurement of fasting
lipid profiles, malonaldehyde and hydroperoxide levels in
patients and controls. Serum total cholesterol level was
determined enzymatically using a Hitachi 912 analyzer
(Roche Diagnostics, GmbH, Mannheim, Germany).
High-density lipoprotein (HDL) cholesterol was meas-
ured using a homogenous method with polyethylene gly-
col modified enzymes and sulphated α-cyclodextrin. Low-
density lipoprotein (LDL) cholesterol was calculated by
the Friedewald equation.
Under oxidative stress, lipid peroxidation serves as an
important contributor to cell injury. The degree of lipid
peroxidation in plasma was determined by measuring
thiobarbituric acid reactive substances (TBARS) [24,25].
In brief, an aliquot of serum (100 μL) was added to 10%
phosphotungstic acid (500 μL) and incubated at room
temperature for 10 minutes. The mixture was centrifuged
at 2000 g for 10 minutes. After removal of supernatant,
thiobarbituric acid (0.67%) was added to the pellet andBMC Pediatrics 2008, 8:20 http://www.biomedcentral.com/1471-2431/8/20
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incubated at 95°C for 1 hour. The amount of malonalde-
hyde formed in the reaction mixture was measured by
spectrophotometer at absorbance of 532 nm. Malonalde-
hyde was used as the standard. The amount of malonalde-
hyde detected correlates to the level of lipid peroxides in
the serum.
Serum hydroperoxide levels were measured by modified
FOX assay [26,27]. In brief, an aliquot of plasma (100 μL)
was added to FOX2 reagent and incubated at room tem-
perature for 30 minutes. The reaction mixture was then
centrifuged at 12,000 g for 5 minutes. Absorbance (at 560
nm) of the supernatant was measured. Hydrogen perox-
ide was used as standard.
Data analysis
Data are presented as mean ± SEM. Differences in demo-
graphic data between patients and control subjects were
compared using unpaired Student's t test. The malonalde-
hyde and hydroperoxides levels among patients with cor-
onary aneurysms, patients without coronary
complications, and control subjects were compared using
simple analysis of variance, with posthoc comparisons by
Tukey test. For the entire cohort, Pearson correlation anal-
ysis was used to assess for possible relationships between
levels of oxidative stress markers and carotid IMT and stiff-
ness index. Stepwise multiple linear regression was used
to identify significant determinants of carotid IMT and
stiffness. A p value of less than 0.05 was considered statis-
tically significant. All statistical analyses were performed
using SPSS version 10.0 (SPSS, Inc., Chicago, Illinois).
Results
A total of 83 Chinese patients living in Hong Kong were
studied, comprising 51 patients with KD and 32 controls
subjects. Those patients were studied at 10.5 ± 0.68 years
after initial diagnosis of KD. Of the 51 patients, 32 had
coronary aneurysms, which were persistent in 26 and had
regressed in 6. All of the patients were asymptomatic,
none required coronary arterial interventions, and 26
patients whom had persistent coronary aneurysms were
maintained on long-term aspirin therapy. None of the
patients were smokers and none had family history of pre-
mature cardiovascular disease. Table 1 shows the demo-
graphic and clinical data of the patients and controls.
There were no significant differences in age, sex distribu-
tion, body mass index, blood pressure and cholesterol lev-
els between patients and controls.
Compared with controls, patients with coronary aneu-
rysms had significantly greater carotid IMT than those
without aneurysm (p = 0.024) and controls (p = 0.006)
(Figure 1a). Likewise, the stiffness index was greater in
patients with than those without coronary aneurysm (p =
0.088) and controls (p < 0.001) (Figure 1b).
The serum levels of malonaldehyde and hydroperoxides,
biomarkers of oxidative stress, in patients with or without
coronary aneurysm and controls are shown in Figure 2.
Compared with controls, patients with coronary aneu-
rysms had significantly higher levels of malonaldehyde
(2.62 ± 0.12 μM  vs  2.22 ± 0.07 μM, p = 0.014) and
hydroperoxides (26.50 ± 1.13 μM vs 22.50 ± 0.62 μM, p =
0.008). By contrast, the levels of malonaldehyde (2.58 ±
0.15 μM vs 2.77 ± 0.17 μM, p = 0.22) and hydroperoxides
(27.2 ± 1.2 μM vs 23.3 ± 3.2 μM) were similar between
patients with persistent aneurysm and those with
regressed ones.
The possibility of a linear trend of the magnitude of oxi-
dative stress was further determined using linear regres-
sion analysis of in the three cohorts: patients with
coronary aneurysms, patients without coronary aneu-
rysms, and controls. A significant trend was observed for
malonaldehyde (P  = 0.018) and hydroperoxides (p =
0.014) levels.
Correlations between levels of oxidative stress markers
and carotid IMT and stiffness index are shown in Figures
3 and 4. The malonaldehyde level correlated positively
with both the carotid IMT (p < 0.001) and stiffness index
(p = 0.001). Similarly, the hydroperoxide level correlated
positively with the carotid IMT (p = 0.034) and stiffness
index (p = 0.021).
Table 1: Demographic data, blood pressure and cholesterol levels of patients and controls
Patients (n = 51) Controls (n = 32) p
Age (yrs) 13.4 ± 0.6 14.6 ± 0.6 0.18
Gender (M/F) 40/11 26/6 1.00
BMI (kg/m2) 19.5 ± 0.6 19.8 ± 0.6 0.71
Systolic blood pressure (mmHg) 112 ± 1.7 113 ± 2.2 0.61
Diastolic blood pressure (mmHg) 65 ± 1.1 66 ± 1.1 0.79
Total cholesterol (mmol/L) 4.09 ± 0.9 4.09 ± 0.1 0.99
HDL cholesterol (mmol/L) 1.11 ± 0.03 1.16 ± 0.03 0.32
LDL cholesterol (mmol/L) 2.64 ± 0.08 2.65 ± 0.1 0.95
BMI = body mass index; HDL = high-density lipoprotein; LDL = low-density lipoproteinBMC Pediatrics 2008, 8:20 http://www.biomedcentral.com/1471-2431/8/20
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Multiple linear regression analysis of the entire cohort was
used to identify significant determinants of carotid IMT
and stiffness index. The independent variables included
age, sex, body mass index, subject grouping (patients with
coronary aneurysms as the referent group with 2 dummies
for patients without coronary complications and con-
trols), systolic and diastolic blood pressures, total choles-
terol, LDL and HDL cholesterols, and malonaldehyde and
hydroperoxides level. Significant determinants of carotid
IMT were subject grouping (β = -0.24, p = 0.025) and
malonaldehyde level (β = 0.31, p = 0.006) (model R2 =
0.20), while significant determinants of carotid stiffness
were subject grouping (β = -0.35, p = 0.001), body mass
index (β = 0.26, p = 0.01), and malonaldehyde level (β =
0.27, p = 0.008) (model R2 = 0.29).
Discussion
The novel findings of the present study are (1) a signifi-
cant increase in the plasma levels of oxidative stress mark-
ers late after the acute illness in patients with a history of
KD and coronary aneurysms and (2) positive correlations
between markers of oxidative stress and carotid IMT and
stiffness. As one of the most sensitive targets for attacks of
oxidative stress are unsaturated fatty acids of cellular lipid
membranes, we measured the levels of hydroperoxides
The serum levels of (A) malonaldehyde and (B) hydroperox- ides in patients with coronary aneurysms, patients without  coronary aneurysms, and controls (*p < 0.05 when com- pared with control group) Figure 2
The serum levels of (A) malonaldehyde and (B) 
hydroperoxides in patients with coronary aneurysms, 
patients without coronary aneurysms, and controls 
(*p < 0.05 when compared with control group). Box-plots showing (A) carotid intima-media thickness, and  (B) stiffness index in patients and controls (*p < 0.05 when  compared with control group) Figure 1
Box-plots showing (A) carotid intima-media thick-
ness, and (B) stiffness index in patients and controls 
(*p < 0.05 when compared with control group).BMC Pediatrics 2008, 8:20 http://www.biomedcentral.com/1471-2431/8/20
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and malonaldehyde, the latter being one of the widely
used indices of oxidative stress.
Previous studies have provided clues for possible exist-
ence of increased oxidative stress in patients after KD.
Deng and colleagues have demonstrated the restoration of
systemic arterial endothelial dysfunction in patients with
and without coronary aneurysms at 1 to 10 years after ini-
tial diagnosis of KD by acute intravenous administration
of vitamin C [28]. They hypothesized that the antioxidant
action of vitamin C might be responsible for the beneficial
effect [29]. Furthermore, endothelin-1, which could
induce superoxide production [30], has been shown to be
increased in KD in the plasma in the acute and recovery
stage [31]. To the best of our knowledge, the present study
is the first to provide direct evidence of increased oxidative
stress in KD patients with coronary aneurysms, which
shed light on the possible underlying mechanisms of the
previously reported, but hitherto unexplained, arterial
dysfunction and intima-media thickening in these
patients.
Arterial dysfunction is increasingly recognized as a long-
term sequel of KD, even in patients without coronary
aneurysms [3-8]. Impaired coronary vasodilatory
response to intracoronary injection of acetylcholine [4,5]
and nitroglycerine [3,5] has been demonstrated at sites of
persistent and regressed aneurysms. Concerns have also
been raised with regard to the possibility of impaired ace-
tylcholine-induced vasodilation at sites with apparently
normal coronary arteries [32]. On the other hand,
Scatter plots showing positive correlations between  hydroperoxide level and (A) carotid intima-media thickness,  and (B) stiffness index Figure 4
Scatter plots showing positive correlations between 
hydroperoxide level and (A) carotid intima-media 
thickness, and (B) stiffness index. Scatter plots showing positive correlations between malonal- dehyde level and (A) carotid intima-media thickness, and (B)  stiffness index Figure 3
Scatter plots showing positive correlations between 
malonaldehyde level and (A) carotid intima-media 
thickness, and (B) stiffness index.BMC Pediatrics 2008, 8:20 http://www.biomedcentral.com/1471-2431/8/20
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impaired brachial flow-mediated dilation [6] and
increased conduit arterial stiffness [8] have been shown in
KD patients with and without coronary complications.
Importantly, endothelial dysfunction and arterial stiffen-
ing that characterize the arterial abnormalities in KD
patients are risk factors for cardiovascular disease and
atherosclerosis. Over the past two decades, accumulating
evidence suggests that endothelial dysfunction may be
caused by accelerated inactivation of nitric oxide by reac-
tive oxygen species, which reduces bioavailability of nitric
oxide [33]. In adult patients with coronary artery disease
[34], non-insulin-dependent diabetes mellitus [35], and
hypertension [36], administration of vitamin C has simi-
larly been shown to improve endothelial dysfunction.
While vascular damage with consequent structural altera-
tion might in part account for arterial stiffening in patients
with a history of KD [8], the alteration of vasomotor tone
secondary to endothelial dysfunction might also be a cul-
prit [6]. The association between oxidative stress and arte-
rial elasticity has recently also been demonstrated by Kals
and coworkers in adult patients with peripheral arterial
disease [37]. In their patients, inverse associations exist
between large and small artery elasticity and urinary 8-iso-
prostaglandins F2α generated as a result of free radical-
mediated peroxidation of arachidonic acid [38]. Proposed
mechanisms include modulation of matrix metalloprotei-
nases associated with destruction of arterial elastic lami-
nae [39], enhancement of smooth muscle tone [40], and
promotion of smooth muscle cell proliferation [41] by
reactive oxygen species. In adults with renovascular hyper-
tension, an inverse relationship between urinary excretion
of 8-hydroxy-2'-deoxygnanosine and acetylcholine-
induced forearm blood flow has been reported [42]. A
recent study has further provided evidence that local oxi-
dative stress as assessed by net production of isoprostane
across the left anterior descending artery territory has a
role in the reduction of nitric oxide bioavailability in
humans with coronary endothelial dysfunction [43].
Hence, it is tempting to speculate that oxidative stress in
KD patients with coronary aneurysms as shown in the
present study might in part account for the observed long-
term systemic arterial dysfunction, albeit the latter is
being documented also in patients without coronary com-
plications [6,8,28].
The next logical question to address is the source of oxida-
tive stress in KD patients. We [44] and others [45] have
shown that high-sensitivity C-reactive protein is elevated
in KD patients with coronary aneurysms late after the
acute illness and implicate the persistence of chronic low-
grade inflammation in these patients. C-reactive protein
has been reported to induce superoxide production in
human aortic endothelial cells as well as in smooth mus-
cle cells [46], possibly through activation of vascular nico-
tinamide adenine dinucleotide/nicotinamide adenine
dinucleotide phosphate oxidase system [47]. The associa-
tion of inflammation and increased oxidative stress
amplifies the cascade that results in vascular damage [48].
Depletion of L-arginine in inflammatory sites has further
been shown to trigger inducible nitric oxide synthase
(iNOS) in macrophages to generate functionally impor-
tant amounts of superoxide anion [49]. Indeed, we have
previously demonstrated that the serum of patients with a
history of KD induces expression iNOS in THP-1 macro-
phages in vitro [50]. Although the role of iNOS in athero-
sclerosis remains to be defined, genetic deficiency in iNOS
has been reported to result reduce atherosclerosis in apol-
ipoprotein E-deficient mice [51] and that chronic treat-
ment of iNOS inhibitors has been shown to limit
progression of preexisting atherosclerosis in hypercholes-
terolaemic rabbits [52]. Undoubtedly, these speculations
of potential sources of oxidative stress in KD patients
require further studies for clarification.
Our findings of increased oxidative stress in KD patients
and its relation with arterial stiffening and intima-media
thickening have important therapeutic implications. Not-
withstanding the reported acute improvement of
endothelial function with intravenous vitamin C admin-
istration in KD patients [28], the usefulness of antioxidant
vitamins to prevent cardiovascular disease in adults with
and without hypercholesterolaemia, end-stage renal dis-
ease, atherosclerosis has been controversial [53,54]. Fur-
ther studies are necessary to elucidate the optimum dose
and type of antioxidants and the impact of long-term anti-
oxidant supplementation on the arterial IMT and stiffness
in KD patients.
A limitation to this study is the potential confounding
influence of aspirin prescribed to KD patients with coro-
nary aneurysms on the levels of oxidative stress markers.
Nonetheless, in a rat model, aspirin has been shown to
attenuate the elevation in aortic superoxide anion levels
induced by angiotensin II [55]. Thus, in patients with per-
sistent coronary aneurysms, if aspirin were to have any
influence on the levels of oxidative markers, the chance of
detecting a significant difference among groups would be
minimized rather than exaggerated.
Conclusion
Increased oxidative stress occurs in patients with a history
of KD late after the acute illness and is associated with
arterial stiffening and intima-medial thickening. Further
research to determine the potential benefits of antioxi-
dants in these patients at risk of premature atherosclerosis
and cardiovascular disease is warranted.
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